BRIEF — Parabilis Medicines Initiates Dose — Ranging Clinical Study Of Zolucatetide In Familial Adenomatous Polyposis

Oct 14 (Reuters) — Parabilis Medicines Inc: Parabilis Medicines Initiates Dose-ranging Clinical Study Of Zolucatetide In Familial Adenomatous Polyposis Parabilis Medicines - To Disclose Additional Fap Data From Phase 1/2 Trial In Q1 2027 Source text:... Further company coverage: PBLS.O (Reuters.Briefs@thomsonreuters.com;)